Post-approval outcomes of voretigene neparvovec (Luxturna®) retinal gene therapy: A systematic review and meta-analysis.
Saved in:
| Title: | Post-approval outcomes of voretigene neparvovec (Luxturna®) retinal gene therapy: A systematic review and meta-analysis. |
|---|---|
| Authors: | Li JXL; Save Sight Institute, The University of Sydney, NSW 2006, Australia; Sydney Eye Hospital, 8 Macquarie Street, Sydney, NSW 2000, Australia. Electronic address: jessicali@outlook.com.au., Rowson AC; Save Sight Institute, The University of Sydney, NSW 2006, Australia; Austin Hospital, 145 Studley Road, Heidelberg, VIC 3084, Australia., Naji L; Save Sight Institute, The University of Sydney, NSW 2006, Australia; University of Canberra, Bruce, ACT 2617, Australia., Li S; Sydney Eye Hospital, 8 Macquarie Street, Sydney, NSW 2000, Australia., Simunovic MP; Save Sight Institute, The University of Sydney, NSW 2006, Australia; Sydney Eye Hospital, 8 Macquarie Street, Sydney, NSW 2000, Australia. |
| Source: | Survey of ophthalmology [Surv Ophthalmol] 2026 Jul 09. Date of Electronic Publication: 2026 Jul 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 0404551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3304 (Electronic) Linking ISSN: 00396257 NLM ISO Abbreviation: Surv Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1879-3304 |
|---|---|
| DOI: | 10.1016/j.survophthal.2026.07.001 |
